Intranasal Administration of Dodecyl Creatine Ester (CBT101) in Healthy Male Subjects

Clinical trial NCT07050316 · COMPLETED

Trial details

NCT number: NCT07050316
Sponsor: Ceres Brain Therapeutics
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Neurologic Diseases, General

Start date: 2025-03-14
Primary completion: 2025-09-26
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.